Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo


Unsupported browser: Your browser does not meet modern web standards. See how it scores »

{ action.text }

Blood Shot

Useful, but barbaric. That’s how San Leandro, CA-based EndoBionics’ CEO Lynn Barr describes balloon angioplasty-the use of a balloon-tipped catheter to open clogged arteries. The procedure itself causes artery-narrowing scarring in about 20 percent of the roughly 600,000 people in the U.S. who undergo it each year. To stop this scarring, mechanical engineer and EndoBionics founder Kirk Seward created a retractable polymer sheath for a steel needle one millimeter long and roughly the diameter of two hairs. After an angioplasty, a surgeon could guide the sheathed needle through an artery in the patient’s leg or neck to the coronary artery. Once the device was in place, a microscale hydraulic system would allow the surgeon to retract the sheath while simultaneously pushing the needle into the artery wall. This way, the device could inject a tiny amount of a blockage-preventing drug directly into the site where scarring and blockage could occur. The technique would deliver the drug much further into the artery walls than other methods being developed for this purpose, Barr says. EndoBionics plans to partner with a yet unnamed medical device company to bring the technology to market in late 2004. Eventually, Barr says, the microneedle could be used to deliver tumor-killing drugs or genes to the brain.


0 comments about this story. Start the discussion »

Reprints and Permissions | Send feedback to the editor

From the Archives


Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me